Shadi Tabibian: The Clinical Power of Patient Stories in Rare Bleeding Disorders
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article by Priyanka Raheja et al., published in RPTH, adding:
“Listening to women matters, especially in bleeding disorders.
Heavy menstrual bleeding (HMB) is often underestimated, yet in women with very rare bleeding disorders, it may be one of the earliest and most important clinical clues.
What I found especially valuable in this article is its focus on the patient perspective.
It reminds us that patient narratives are not just stories — they are clinically meaningful data.
When women describe the severity of bleeding, fatigue, anemia, disruption of daily life, and emotional burden, they are providing information that can directly improve recognition, diagnosis, and care.
This paper is an important reminder that better medicine begins not only with tests and algorithms, but also with listening carefully.
Dealing with heavy menstrual bleeding in very rare bleeding disorders: From a patient’s perspective”
Title: Dealing with heavy menstrual bleeding in very rare bleeding disorders: from a patient’s perspective
Authors: Priyanka Raheja, Rezan Abdul-Kadir, Maja Johanne Søndergaard Knudsen, Christina Burgess, Saskia E.M. Schols
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 17:54Tareq Abadl: Extravascular Hemolysis The High-Yield Guide
-
Sep 3, 2026, 17:48Isabel Sá: Starting a New Chapter as a Clinical Scientist in Molecular Genetics and Haematology
-
Sep 3, 2026, 17:40Chiwoo Oh: AS01B Adjuvant and Long-Term Immune Reprogramming After Shingrix Vaccination
-
Sep 3, 2026, 17:35Key Developments in Transfusion Medicine and Biotherapies in 2025 – AABB
-
Sep 3, 2026, 17:24N. Mariana S. Vasquez: JAK2 Mutations The High-Yield Map of Myeloproliferative Neoplasms
-
Sep 3, 2026, 17:08Khusi Dhara: Why Women Need to Pay Attention to Iron
-
Sep 3, 2026, 16:54Ralf Ludwig։ Testing Human-Targeted Therapies in a Human Immune System
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 16:10Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia